Allosteros

About:

Allosteros Therapeutics Inc. engages in discovery and development of breakthrough small molecule drugs.

Top Investors: Broadview Ventures

Description:

Allosteros Therapeutics Inc. engages in discovery and development of breakthrough small molecule drugs that target allosteric sites on key proteins in disease pathways. Allosteros Therapeutics Inc. was incorporated in 2009 and is based in Palo Alto, California.

Total Funding Amount:

$1.29M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2009-01-01

Founders:

Howard Schulman, Mark Anderson

Number of Employees:

1-10

Last Funding Date:

2012-08-20

IPO Status:

Private

Industries: